Outcomes and management of patients with mantle cell lymphoma after progression on brexucabtagene autoleucel therapy
Author:
Affiliation:
1. Department of Lymphoma and Myeloma The University of Texas MD Anderson Cancer Center Houston TX USA
Publisher
Wiley
Subject
Hematology
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1111/bjh.17197
Reference9 articles.
1. KTE-X19 CAR T-Cell Therapy in Relapsed or Refractory Mantle-Cell Lymphoma
2. High‐risk mantle cell lymphoma: definition, current challenges, and management;Jain P.;J. Clin. Oncol.,2019
3. Genomic profiles and clinical outcomes of de novo blastoid/pleomorphic MCL are distinct from those of transformed MCL
4. TP53 mutations identify younger mantle cell lymphoma patients who do not benefit from intensive chemoimmunotherapy
5. Complex karyotype in patients with mantle cell lymphoma predicts inferior survival and poor response to intensive induction therapy
Cited by 30 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Chimeric Antigen Receptor Therapy in Lymphoma;Manual of Hematopoietic Cell Transplantation and Cellular Therapies;2024
2. Chimeric antigen receptor T cells to target CD79b in B-cell lymphomas;Journal for ImmunoTherapy of Cancer;2023-11
3. Effects of Cannabidiol on the Functions of Chimeric Antigen Receptor T Cells in Hematologic Malignancies;Cannabis and Cannabinoid Research;2023-10-25
4. Novel treatment for mantle cell lymphoma – impact of BTK inhibitors and beyond;Leukemia & Lymphoma;2023-10-06
5. The CAR‐HEMATOTOX score identifies patients at high risk for hematological toxicity, infectious complications, and poor treatment outcomes following brexucabtagene autoleucel for relapsed or refractory MCL;American Journal of Hematology;2023-08-16
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3